Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Novel cysteinyl leukotriene receptor signaling in regulating cellular, and molecular events in lung inflammation

Award Number: R01HL178459
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/09/2025
PERIOD OF PERFORMANCE END DATE: 02/28/2029

Group Awards By:

View Award Description

Novel cysteinyl leukotriene receptor signaling in regulating cellular, and molecular events in lung inflammation - Project summary: Cysteinyl leukotrienes (cys-LTs; LTC4, LTD4, and LTE4) play an important role in asthma, allergy, and inflammatory bowel diseases via their receptors, CysLT1R and CysLT2R. However, the role of cys-LTs in regulating the inflammatory and proliferative phenotypes of macrophages (MФ) or their role in MФ-mediated lung inflammation is not well defined. Our preliminary work revealed a previously unidentified role for CysLT1R in balancing MФs’ inflammatory potential, metabolic function, and proliferation in vitro, and a role in driving LPS- mediated lung inflammation in vivo. Based on these findings, we hypothesize that the presence of CysLT1R drives the inflammatory state of MФs and lung inflammation in response to LPS. Further, since CysLT1R and CysLT2R antagonize each other, CysLT1R may act as a molecular brake for MФ hyper-proliferation via binding to and inhibiting CysLT2R. We propose to test this hypothesis in three aims. In Aim 1, we will determine the mechanistic aspects of how CysLT1R promotes the hyper-inflammatory MФ phenotype in vitro and analyze how CysLT1R influences the resident and recruited immune population in the lung in response to acute lung injury (ALI). In Aim 2, we will elucidate how CysLT1R suppresses MФ proliferation, and metabolism, and we will explore its antagonism towards CysLT2R in deciding the MФ activation state. Finally, in Aim 3, we will determine the pathophysiological significance of myeloid CysLT1R signaling in mediating lung inflammation in murine ALI models. Further, we will explore the therapeutic potential of blocking CysLT1R using MK571/Singulair, an FDA- approved asthma drug. Although a few reports have suggested the benefits of Singulair in reducing pulmonary inflammation during LPS-ALI and COVID-19, neither the mechanistic aspects, nor its prophylaxis vs therapeutic effect on all ALI parameters, were previously addressed. The successful completion of our project will unravel the previously unknown unique roles of CysLTR in influencing MФ function and its role in lung inflammation/injury.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $567,874 )
2026	2026	UNIVERSITY OF TOLEDO	3000 ARLINGTON AVE	TOLEDO	OH	43614	LUCAS	USA	Lung Diseases Research	001	2	3/25/2026	NON-COMPETING CONTINUATION	$17,384
2026	2026	UNIVERSITY OF TOLEDO	3000 ARLINGTON AVE	TOLEDO	OH	43614	LUCAS	USA	Lung Diseases Research	000	2	3/5/2026	NON-COMPETING CONTINUATION	$550,490
														Subtotal = $567,874

Issue Date FY: 2025 ( Subtotal = $579,309 )
2025	2025	UNIVERSITY OF TOLEDO	3000 ARLINGTON AVE	TOLEDO	OH	43614	LUCAS	USA	Lung Diseases Research	000	1	6/9/2025	NEW	$579,309
														Subtotal = $579,309

Grand Total All Awards = $1,147,183

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Novel cysteinyl leukotriene receptor signaling in regulating cellular, and molecular events in lung inflammation

Award Number: R01HL178459

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/09/2025

PERIOD OF PERFORMANCE END DATE: 02/28/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer